Recent publications
Article
Bilateral Remote Ischemic Conditioning in Children Trial Investigators, Drury, NE, Doorn, CV, Woolley, RL, Amos-Hirst, RJ, Bi, R, Spencer, CM, Morris, KP, Montgomerie, J, Stickley, J, Crucean, A, Gill, A, Hill, M, Weber, RJM, Najdekr, L, Jankevics, A, Southam, AD, Lloyd, GR, Jaber, O, Kassai, I, Pelella, G, Khan, NE, Botha, P, Barron, DJ, Madhani, M, Dunn, WB, Ives, NJ, Kirchhof, P & Jones, TJ 2024, 'Bilateral Remote Ischemic Conditioning in Children: a two-center, double-blind, randomized controlled trial in young children undergoing cardiac surgery', The Journal of Thoracic and Cardiovascular Surgery, vol. 18, pp. 193-208. https://doi.org/10.1016/j.xjon.2024.02.018
Spencer, S, Desborough, R, Mehta, S, Ives, N & Bhandari, S 2024, 'Cystatin C vs Creatinine eGFR in Advanced CKD: an analysis of the STOP-ACEi Trial ', Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfae268
Ives, N, Woolley, R, Saleem , MA, Moakes, C, Waters, A, Gilbert, RD, Jarrett, H, Brettell, E, Nash, S, Farmer, LK, Ourradi, K & Johnson, SA 2024, 'Efficacy and safety of eculizumab in children with Shiga-toxin-producing Escherichia coli haemolytic uraemic syndrome: the ECUSTEC RCT', Efficacy and Mechanism Evaluation, vol. 11, no. 11, pp. 1-78. https://doi.org/10.3310/RFTY4766
Bhandari, S, Mehta, S, Khawaja, A, Cleland, JGF, Rowland, N & Cockwell, P 2024, 'Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease', Kidney International, vol. 105, no. 1, pp. 200-208. https://doi.org/10.1016/j.kint.2023.09.012
Adams, R, Jordan, R, Maher, A, Adab, P, Barrett, T, Bevan, S, Cooper, L, DuRand, I, Edwards, F, Hardy, P, Harris, C, Heneghan, NR, Jolly, K, Jowett, S, Marshall, T, O'Hara, M, Poyner, C, Rai, K, Rickards, H, Riley, R, Ives, N, Sadhra, S, Tearne, S, Walters, G & Sapey, E 2024, 'Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCT', Health and Social Care Delivery Research, vol. 12, no. 23, pp. 1-105. https://doi.org/10.3310/KDST3869
Sackley, CM, Rick, C, Brady, MC, Woolley, R, Burton, C, Patel, S, Masterson-Algar, P, Nicoll, A, Smith, CH, Jowett, S, Ives, N, Beaton, G, Dickson, S, Ottridge, R, Sharp, L, Nankervis, H, Clarke, CE & PD COMM Collaborative Group 2024, 'Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial', BMJ, vol. 386, e078341. https://doi.org/10.1136/bmj-2023-078341
Crombie, N, Doughty, HA, Bishop, JRB, Desai, A, Dixon, EF, Hancox, JM, Herbert, MJ, Leech, C, Lewis, SJ, Nash, MR, Naumann, DN, Piper, K, Slinn, G, Smith, H, Smith, IM, Wale, RK, Wilson, A, Crombie, A, Midwinter, M, Ives, N & Perkins, GD 2024, 'Resuscitation with pre-hospital blood products in adults with trauma-related haemorrhagic shock: the RePHILL RCT', Efficacy and Mechanism Evaluation, vol. 11, no. 2. https://doi.org/10.3310/TDNB9214
Krouwel, M, Greenfield, SM, Chalkley, A, Sanders, JP, Parretti, HM, Gokal, K, Jolly, K, Skrybant, M, Biddle, SJH, Greaves, C, Maddison, R, Mutrie, N, Ives, N, Esliger, DW, Sherar, L, Edwardson, CL, Yates, T, Frew, E, Tearne, S, Daley, AJ & Kwaghe, AV (ed.) 2023, 'Promoting participation in physical activity through Snacktivity: A qualitative mixed methods study', PLOS One, vol. 18, no. 9, e0291040. https://doi.org/10.1371/journal.pone.0291040
Daley, AJ, Griffin, RA, Moakes, CA, Sanders, JP, Skrybant, M, Ives, N, Maylor, B, Greenfield, SM, Gokal, K, Parretti, HM, Biddle, SJH, Greaves, C, Maddison, R, Mutrie, N, Esliger, DW, Sherar, L, Edwardson, CL, Yates, T, Frew, E, Tearne, S & Jolly, K 2023, 'Snacktivity™ to promote physical activity and reduce future risk of disease in the population: protocol for a feasibility randomised controlled trial and nested qualitative study', Pilot and Feasibility Studies, vol. 9, no. 1, 45. https://doi.org/10.1186/s40814-023-01272-8
PREDNOS Collaborative Group, NIHR Medicines for Children Research Network Nephrology Clinical Studies Group, Afentou, N, Frew, E, Mehta, S, Rowland, N, Woolley, R, Brettell, E, Khan, A, Milford, D, Bockenhauer, D, Saleem , MA, Hall, AS, Koziell, A, Maxwell, H, Hegde , S, Finlay, ER, Gilbert, RD, Jones, C, McKeever, K, Cook, W, Webb, NJA & Christian, MT 2022, 'Economic evaluation of using daily prednisolone versus placebo at the time of an upper respiratory tract infection for the management of children with steroid-sensitive nephrotic syndrome: a model-based analysis', PharmacoEconomics, vol. 6, no. 4, pp. 605-617. https://doi.org/10.1007/s41669-022-00334-6
Jayne, D, Walsh, M, Merkel, PA, Peh, CA, Szpirt, W, Puéchal, X, Fujimoto, S, Hawley, C, Khalidi, N, Jones, R, Flossmann, O, Wald, R, Girard, L, Levin, A, Gregorini, G, Harper, L, Clark, W, Pagnoux, C, Specks, U, Smyth, L, Ito-Ihara, T, De zoysa, J, Brezina, B, Mazzetti, A, Mcalear, CA, Reidlinger, D, Mehta, S, Ives, N, Brettell, EA, Jarrett, H, Wheatley, K, Broadhurst, E, Casian, A & Pusey, CD 2022, 'Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT', Health Technology Assessment, vol. 26, no. 38, pp. 1-60. https://doi.org/10.3310/PNXB5040
Abstract
Bhandari, S, Mehta, S, Ives, N & Cockwell, P 2024, 'WCN24-318: Utility of 2-year Kidney Failure Risk Equation for advanced chronic kidney disease: analysis from the STOP ACEi Trial', Kidney International Reports, vol. 9, no. 4, pp. S81-S82. https://doi.org/10.1016/j.ekir.2024.02.174
Spencer, S, Desborough, R, Mehta, S, Rowland, N & Bhandari, S 2024, 'WCN24-398: Report on STOP-ACEi trial: reviewing cystatin C levels in CKD patients', Kidney International Reports, vol. 9, no. 4, pp. S83-S83. https://doi.org/10.1016/j.ekir.2024.02.176
Comment/debate
Crombie, N, Bishop, J, Ives, N & Perkins, GD 2022, 'Prehospital blood transfusion for haemorrhagic shock – Authors' reply', The Lancet Haematology, vol. 9, no. 6, pp. e397-e397. https://doi.org/10.1016/S2352-3026(22)00137-5
Letter
Bhandari, S, Mehta, S, Rowland, N & Cockwell, P 2023, 'Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial', Nephrology, Dialysis, Transplantation. https://doi.org/10.1093/ndt/gfad263
View all publications in research portal